Cargando…

Timing of cardiac resynchronization therapy implantation

AIMS: The optimum timing of cardiac resynchronization therapy (CRT) implantation is unknown. We explored long-term outcomes after CRT in relation to the time interval from a first heart failure hospitalization (HFH) to device implantation. METHODS AND RESULTS: A database covering the population of E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leyva, Francisco, Zegard, Abbasin, Patel, Peysh, Stegemann, Berthold, Marshall, Howard, Ludman, Peter, Walton, Jamie, de Bono, Joseph, Boriani, Giuseppe, Qiu, Tian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227865/ https://www.ncbi.nlm.nih.gov/pubmed/36944529 http://dx.doi.org/10.1093/europace/euad059

Ejemplares similares

Improved prognosis after cardiac resynchronization therapy over a decade
por: Leyva, Francisco, et al.
Publicado: (2023)

Changes in QRS Area and QRS Duration After Cardiac Resynchronization Therapy Predict Cardiac Mortality, Heart Failure Hospitalizations, and Ventricular Arrhythmias
por: Okafor, Osita, et al.
Publicado: (2019)

Survival after cardiac resynchronization therapy: results from 50 084 implantations
por: Leyva, Francisco, et al.
Publicado: (2019)

Cardiac operations and interventions during the COVID-19 pandemic: a nationwide perspective
por: Leyva, Francisco, et al.
Publicado: (2021)

Long‐term outcomes of cardiac resynchronization therapy in adult congenital heart disease
por: Leyva, Francisco, et al.
Publicado: (2019)

Cardiac Resynchronization Therapy Using Quadripolar Versus Non‐Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single‐Site Left Ventricular Pacing: Impact on Survival and Heart Failure Hospitalization
por: Leyva, Francisco, et al.
Publicado: (2017)

Diagnostic yield of a heart failure referral pathway using N-terminal pro-brain natriuretic peptide
por: Zegard, Abbasin, et al.
Publicado: (2023)

Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy
por: Leyva, Francisco, et al.
Publicado: (2018)

Renal function and the long‐term clinical outcomes of cardiac resynchronization therapy with or without defibrillation
por: Leyva, Francisco, et al.
Publicado: (2019)

Sex‐Specific Differences in Survival and Heart Failure Hospitalization After Cardiac Resynchronization Therapy With or Without Defibrillation
por: Leyva, Francisco, et al.
Publicado: (2019)

Greyzone myocardial fibrosis and ventricular arrhythmias in patients with a left ventricular ejection fraction >35%
por: Zegard, Abbasin, et al.
Publicado: (2021)

Long‐Term Outcomes of Cardiac Resynchronization Therapy Using Apical Versus Nonapical Left Ventricular Pacing
por: Leyva, Francisco, et al.
Publicado: (2018)

Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy
por: Foley, Paul W.X., et al.
Publicado: (2009)

Cardiac device implantation and device usage in Fabry and hypertrophic cardiomyopathy
por: Vijapurapu, Ravi, et al.
Publicado: (2022)

Cardiac resynchronization therapy guided by cardiovascular magnetic resonance
por: Leyva, Francisco
Publicado: (2010)

What is treatment success in cardiac resynchronization therapy?
por: Foley, Paul W.X., et al.
Publicado: (2009)

Cardiac resynchronization therapy during rest and exercise: comparison of two optimization methods
por: Valzania, Cinzia, et al.
Publicado: (2008)

Successful Catheter Ablation of Ventricular Tachycardia Precipitated by Cardiac Resynchronization Therapy
por: Rauf, Muhammad Atif, et al.
Publicado: (2023)

Economic analysis of remote monitoring in patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators in the Trento area, Italy
por: Marini, Massimiliano, et al.
Publicado: (2023)

Acute Hemodynamic Effects of Simultaneous and Sequential Multi-Point Pacing in Heart Failure Patients With an Expected Higher Rate of Sub-response to Cardiac Resynchronization Therapy: Results of Multicenter SYNSEQ Study
por: Sterliński, Maciej, et al.
Publicado: (2022)

Left ventricular scar and the acute hemodynamic effects of multivein and multipolar pacing in cardiac resynchronization
por: Jackson, Tom, et al.
Publicado: (2018)

The economic impact of remote control in patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators: single center experience
por: Marini, M, et al.
Publicado: (2023)

Outcomes after transvenous defibrillator implantation in cardiac sarcoidosis: A systematic review
por: Taha, Ahmed, et al.
Publicado: (2022)

Clinical outcomes and costs of cardiac revascularisation in England and New York state
por: Leyva, Francisco, et al.
Publicado: (2018)

Thoracoscopic Left Ventricular Lead Implantation in Cardiac Resynchronization Therapy
por: Jeong, Dong Seop, et al.
Publicado: (2012)

Mid-Term Outcomes in Patients Implanted with Cardiac Resynchronization Therapy
por: Lee, Sung Ho, et al.
Publicado: (2014)

Pneumopericardium and Pneumomediastinum After Implantation of a Cardiac Resynchronization Pacemaker
por: Green, Peregrine G., et al.
Publicado: (2019)

Anatomy of the coronary sinus with regard to cardiac resynchronization therapy implantation
por: Borgquist, Rasmus, et al.
Publicado: (2022)

Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance
por: Leyva, Francisco, et al.
Publicado: (2011)

Cardiac resynchronization therapy: mechanisms of action and scope for further improvement in cardiac function
por: Jones, Siana, et al.
Publicado: (2017)

Thoracoscopic Implantation of Epicardial Left Ventricular Lead for Cardiac Resynchronization Therapy
por: Kim, Hye Ree, et al.
Publicado: (2022)

MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy): cardiac resynchronization therapy towards early management of heart failure
por: Breithardt, Günter
Publicado: (2009)

When is an optimization not an optimization? Evaluation of clinical implications of information content (signal-to-noise ratio) in optimization of cardiac resynchronization therapy, and how to measure and maximize it
por: Pabari, Punam A., et al.
Publicado: (2010)

Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33)
por: Foo, Fang Shawn, et al.
Publicado: (2019)

QRS pattern and improvement in right and left ventricular function after cardiac resynchronization therapy: a radionuclide study
por: Domenichini, Giulia, et al.
Publicado: (2012)

Potential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study
por: Sack, Stefan, et al.
Publicado: (2011)

Chylothorax after cardiac resynchronization therapy-pacemaker implantation: A case report
por: Okuya, Yoshiyuki, et al.
Publicado: (2021)

Comparative cost analysis of implanting devices in different cardiac resynchronization therapeutic strategies
por: Chen, Mengna, et al.
Publicado: (2023)

Cardiac Resynchronization Therapy in Children
por: Batra, Anjan S, et al.
Publicado: (2009)

Advances in Cardiac Resynchronization Therapy
por: Jafferani, Asif, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r6acjf0iiviaodckskutj03451